<div id="readability-page-1">IN8bio (INAB) entered into a definitive securities purchase agreement for a private placement of up to ~$40.2M in gross proceeds, priced at-the-market. The initial tranche is expected to raise ~$20.1M and fund operations into the first half of 2027. At the initial closing, IN8bio will sell 5.13M shares at $1.38/share and pre-funded warrants for up ...</div>

INAB

<p>IN8bio 宣布了一项最高达 4020 万美元的私募协议，首期融资为 2010 万美元，以资助运营直到 2027 年。该公司将以每股 1.38 美元的价格出售股票和认股权证，并根据里程碑可能获得额外资金。所得款项将支持研究和项目，预计初次交割将在 2025 年 12 月 22 日之前完成。INAB 股票在盘前上涨了 5%</p>

IN8bio 宣布进行高达 4020 万美元的市场定向增发